Antibody Pharmacokinetics (PK) The Jackson Laboratory The limitation of lipidation: Conversion of semaglutide from once weekly to once monthly dosing PNAS Prediction of Human Pharmacokinetics of E0703, a Novel Radioprotective Agent, Using Physiologically Based Pharmacokinetic Modeling and an Interspecies Extrapolation Approach Results from a phase 1, randomized, double blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers Hypertension Research